Showing results (1-10 of 461) with videos related to
Sort By:
Pageof 47
Expert Opinion on Emerging Drugs|May 6, 2016
Emerging targeted therapies for melanomaDouglas B Johnson, Megan H Pollack, Jeffrey A SosmanJournal of the National Comprehensive Cancer Network : JNCCN|May 10, 2014
BRAFV600E-mutant melanoma presenting with cardiac involvementDouglas B Johnson, Jeffrey A SosmanJAMA Oncology|July 17, 2015
Therapeutic Advances and Treatment Options in Metastatic MelanomaDouglas B Johnson, Jeffrey A SosmanCurrent Treatment Options in Oncology|February 20, 2013
Update on the targeted therapy of melanomaDouglas B Johnson, Jeffrey A SosmanTherapeutic Advances in Medical Oncology|March 11, 2015
Nivolumab in melanoma: latest evidence and clinical potentialDouglas B Johnson, Chengwei Peng, Jeffrey A SosmanExpert Opinion on Biological Therapy|March 28, 2015
Trametinib in the treatment of melanomaRamya Thota, Douglas B Johnson, Jeffrey A SosmanExpert Review of Clinical Immunology|July 19, 2016
PD-1/PD-L1 blockade in renal cell cancerKathryn E Beckermann, Douglas B Johnson, Jeffrey A SosmanCurrent Oncology Reports|January 9, 2016
Molecular Targeted Therapy Approaches for BRAF Wild-Type MelanomaRomany A N Johnpulle, Douglas B Johnson, Jeffrey A SosmanClinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 5, 2014
Molecular pathways: targeting NRAS in melanoma and acute myelogenous leukemiaDouglas B Johnson, Keiran S M Smalley, Jeffrey A SosmanCancer|April 18, 2018
Melanoma: What do all the mutations mean?Elizabeth J Davis, Douglas B Johnson, Jeffrey A Sosman, et al.Pageof 47